Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes

Ping Xu, Yougui Wu, Yiliang Zhu, Getachew Dagne, Giffe Johnson, David Cuthbertson, Jeffrey P. Krischer, Jay M Sosenko, Jay S Skyler

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

OBJECTIVE - In this investigation we evaluated nine metabolic indexes from intravenous glucose tolerance tests (IVGTTs) and oral glucose tolerance tests (OGTTs) in an effort to determine their prognostic performance in predicting the development of type 1 diabetes in those with moderate risk, as defined by familial relation to a type 1 diabetic individual, a positive test for islet cell antibodies and insulin autoantibody, but normal glucose tolerance. RESEARCH DESIGN AND METHODS - Subjects (n = 186) who had a projected risk of 25-50% for developing type 1 diabetes within 5 years were followed until clinical diabetes onset or the end of the study as part of the Diabetes Prevention Trial-Type 1. Prognostic performance of the metabolic indexes was determined using receiver operating characteristic (ROC) curve and survival analyses. RESULTS - Two-hour glucose from an OGTT most accurately predicted progression to disease compared with all other metabolic indicators with an area under the ROC curve of 0.67 (95% CI 0.59-0.76), closely followed by the ratio of first-phase insulin response (FPIR) to homeostasis model assessment of insulin resistance (HOMA-IR) with an area under the curve value of 0.66. The optimal cutoff value for 2-h glucose (114 mg/dl) maintained sensitivity and specificity values >0.60. The hazard ratio for those with 2-h glucose ≥114 mg/dl compared with those with 2-h glucose <114 mg/dl was 2.96 (1.67-5.22). CONCLUSIONS - The ratio of FPIR to HOMA-IR from an IVGTT provided accuracy in predicting the development of type 1 diabetes similar to that of 2-h glucose from an OGTT, which, because of its lower cost, is preferred. The optimal cutoff value determined for 2-h glucose provides additional guidance for clinicians to identify subjects for potential prevention treatments before the onset of impaired glucose tolerance.

Original languageEnglish
Pages (from-to)2508-2513
Number of pages6
JournalDiabetes Care
Volume33
Issue number12
DOIs
StatePublished - Dec 1 2010

Fingerprint

Type 1 Diabetes Mellitus
Glucose Tolerance Test
Glucose
Insulin
ROC Curve
Insulin Resistance
Homeostasis
Glucose Intolerance
Survival Analysis
Autoantibodies
Area Under Curve
Disease Progression
Research Design
Costs and Cost Analysis
Sensitivity and Specificity

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this

Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes. / Xu, Ping; Wu, Yougui; Zhu, Yiliang; Dagne, Getachew; Johnson, Giffe; Cuthbertson, David; Krischer, Jeffrey P.; Sosenko, Jay M; Skyler, Jay S.

In: Diabetes Care, Vol. 33, No. 12, 01.12.2010, p. 2508-2513.

Research output: Contribution to journalArticle

Xu, P, Wu, Y, Zhu, Y, Dagne, G, Johnson, G, Cuthbertson, D, Krischer, JP, Sosenko, JM & Skyler, JS 2010, 'Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes', Diabetes Care, vol. 33, no. 12, pp. 2508-2513. https://doi.org/10.2337/dc10-0802
Xu P, Wu Y, Zhu Y, Dagne G, Johnson G, Cuthbertson D et al. Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes. Diabetes Care. 2010 Dec 1;33(12):2508-2513. https://doi.org/10.2337/dc10-0802
Xu, Ping ; Wu, Yougui ; Zhu, Yiliang ; Dagne, Getachew ; Johnson, Giffe ; Cuthbertson, David ; Krischer, Jeffrey P. ; Sosenko, Jay M ; Skyler, Jay S. / Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes. In: Diabetes Care. 2010 ; Vol. 33, No. 12. pp. 2508-2513.
@article{ae195523fa574a648163d6eb403ea633,
title = "Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes",
abstract = "OBJECTIVE - In this investigation we evaluated nine metabolic indexes from intravenous glucose tolerance tests (IVGTTs) and oral glucose tolerance tests (OGTTs) in an effort to determine their prognostic performance in predicting the development of type 1 diabetes in those with moderate risk, as defined by familial relation to a type 1 diabetic individual, a positive test for islet cell antibodies and insulin autoantibody, but normal glucose tolerance. RESEARCH DESIGN AND METHODS - Subjects (n = 186) who had a projected risk of 25-50{\%} for developing type 1 diabetes within 5 years were followed until clinical diabetes onset or the end of the study as part of the Diabetes Prevention Trial-Type 1. Prognostic performance of the metabolic indexes was determined using receiver operating characteristic (ROC) curve and survival analyses. RESULTS - Two-hour glucose from an OGTT most accurately predicted progression to disease compared with all other metabolic indicators with an area under the ROC curve of 0.67 (95{\%} CI 0.59-0.76), closely followed by the ratio of first-phase insulin response (FPIR) to homeostasis model assessment of insulin resistance (HOMA-IR) with an area under the curve value of 0.66. The optimal cutoff value for 2-h glucose (114 mg/dl) maintained sensitivity and specificity values >0.60. The hazard ratio for those with 2-h glucose ≥114 mg/dl compared with those with 2-h glucose <114 mg/dl was 2.96 (1.67-5.22). CONCLUSIONS - The ratio of FPIR to HOMA-IR from an IVGTT provided accuracy in predicting the development of type 1 diabetes similar to that of 2-h glucose from an OGTT, which, because of its lower cost, is preferred. The optimal cutoff value determined for 2-h glucose provides additional guidance for clinicians to identify subjects for potential prevention treatments before the onset of impaired glucose tolerance.",
author = "Ping Xu and Yougui Wu and Yiliang Zhu and Getachew Dagne and Giffe Johnson and David Cuthbertson and Krischer, {Jeffrey P.} and Sosenko, {Jay M} and Skyler, {Jay S}",
year = "2010",
month = "12",
day = "1",
doi = "10.2337/dc10-0802",
language = "English",
volume = "33",
pages = "2508--2513",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "12",

}

TY - JOUR

T1 - Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes

AU - Xu, Ping

AU - Wu, Yougui

AU - Zhu, Yiliang

AU - Dagne, Getachew

AU - Johnson, Giffe

AU - Cuthbertson, David

AU - Krischer, Jeffrey P.

AU - Sosenko, Jay M

AU - Skyler, Jay S

PY - 2010/12/1

Y1 - 2010/12/1

N2 - OBJECTIVE - In this investigation we evaluated nine metabolic indexes from intravenous glucose tolerance tests (IVGTTs) and oral glucose tolerance tests (OGTTs) in an effort to determine their prognostic performance in predicting the development of type 1 diabetes in those with moderate risk, as defined by familial relation to a type 1 diabetic individual, a positive test for islet cell antibodies and insulin autoantibody, but normal glucose tolerance. RESEARCH DESIGN AND METHODS - Subjects (n = 186) who had a projected risk of 25-50% for developing type 1 diabetes within 5 years were followed until clinical diabetes onset or the end of the study as part of the Diabetes Prevention Trial-Type 1. Prognostic performance of the metabolic indexes was determined using receiver operating characteristic (ROC) curve and survival analyses. RESULTS - Two-hour glucose from an OGTT most accurately predicted progression to disease compared with all other metabolic indicators with an area under the ROC curve of 0.67 (95% CI 0.59-0.76), closely followed by the ratio of first-phase insulin response (FPIR) to homeostasis model assessment of insulin resistance (HOMA-IR) with an area under the curve value of 0.66. The optimal cutoff value for 2-h glucose (114 mg/dl) maintained sensitivity and specificity values >0.60. The hazard ratio for those with 2-h glucose ≥114 mg/dl compared with those with 2-h glucose <114 mg/dl was 2.96 (1.67-5.22). CONCLUSIONS - The ratio of FPIR to HOMA-IR from an IVGTT provided accuracy in predicting the development of type 1 diabetes similar to that of 2-h glucose from an OGTT, which, because of its lower cost, is preferred. The optimal cutoff value determined for 2-h glucose provides additional guidance for clinicians to identify subjects for potential prevention treatments before the onset of impaired glucose tolerance.

AB - OBJECTIVE - In this investigation we evaluated nine metabolic indexes from intravenous glucose tolerance tests (IVGTTs) and oral glucose tolerance tests (OGTTs) in an effort to determine their prognostic performance in predicting the development of type 1 diabetes in those with moderate risk, as defined by familial relation to a type 1 diabetic individual, a positive test for islet cell antibodies and insulin autoantibody, but normal glucose tolerance. RESEARCH DESIGN AND METHODS - Subjects (n = 186) who had a projected risk of 25-50% for developing type 1 diabetes within 5 years were followed until clinical diabetes onset or the end of the study as part of the Diabetes Prevention Trial-Type 1. Prognostic performance of the metabolic indexes was determined using receiver operating characteristic (ROC) curve and survival analyses. RESULTS - Two-hour glucose from an OGTT most accurately predicted progression to disease compared with all other metabolic indicators with an area under the ROC curve of 0.67 (95% CI 0.59-0.76), closely followed by the ratio of first-phase insulin response (FPIR) to homeostasis model assessment of insulin resistance (HOMA-IR) with an area under the curve value of 0.66. The optimal cutoff value for 2-h glucose (114 mg/dl) maintained sensitivity and specificity values >0.60. The hazard ratio for those with 2-h glucose ≥114 mg/dl compared with those with 2-h glucose <114 mg/dl was 2.96 (1.67-5.22). CONCLUSIONS - The ratio of FPIR to HOMA-IR from an IVGTT provided accuracy in predicting the development of type 1 diabetes similar to that of 2-h glucose from an OGTT, which, because of its lower cost, is preferred. The optimal cutoff value determined for 2-h glucose provides additional guidance for clinicians to identify subjects for potential prevention treatments before the onset of impaired glucose tolerance.

UR - http://www.scopus.com/inward/record.url?scp=79951710703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951710703&partnerID=8YFLogxK

U2 - 10.2337/dc10-0802

DO - 10.2337/dc10-0802

M3 - Article

VL - 33

SP - 2508

EP - 2513

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 12

ER -